Weekend reads: Is science self-correcting?; peer review’s “undue emotional burdens;” retractions at Science

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a dental researcher who is up to 18 pulled papers; … Continue reading Weekend reads: Is science self-correcting?; peer review’s “undue emotional burdens;” retractions at Science

Caught Our Notice: Should publicly funded research tools be free for researchers to use?

Title: Adherence to Adjuvant Neuropathic Pain Medications in a Palliative Care Clinic What Caught Our Attention: We’ve found a fourth retraction for the unlicensed use of a common research tool, an issue we explored in depth for Science last year. Quick recap: When researchers use a copyrighted questionnaire (MMAS-8) without permission, they get a call … Continue reading Caught Our Notice: Should publicly funded research tools be free for researchers to use?

Caught Our Notice: Using this research tool? You’d better ask first

Title: Patient Education After CABG: Are We Teaching the Wrong Information? What Caught Our Attention: We’ve written about the controversy surrounding a commonly used tool to measure whether patients are sticking to their drug regimen, known as the Morisky Medication Adherence Scale (MMAS-8). It can cost thousands of dollars — and using it without payment/permission … Continue reading Caught Our Notice: Using this research tool? You’d better ask first

If you use this research tool without permission, you’ll hear about it

Sometimes, a seemingly run-of-the-mill retraction notice turns out to be much less straightforward. Such was the case with a recent retraction of a 2016 paper in a journal published by the U.S. Centers for Disease Control and Prevention, apparently over permission to use an evaluation scale designed to test whether patients take their medications as … Continue reading If you use this research tool without permission, you’ll hear about it